Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Summary

The protocol is a Simon's 2-stage, non-randomized, open label, multi-site, phase 2 trial for patients with advanced metastatic, recurrent and unresectable malignant melanoma that has recurred or relapsed after prior anti-PD-(L)1 therapy.

Timeline

Start

2027-03-01

Primary completion

2029-03-01

Completion

2029-09-30

Drugs

Indications